Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance

With ongoing resistance problems against the marketed EGFR inhibitors having a quinazoline core scaffold there is a need for the development of novel inhibitors having a modified scaffold and, thus, expected lower EGFR resistance problems. An additional problem concerning EGFR inhibitor resistance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Tim, Najjar, Abdulkarim, Totzke, Frank, Schächtele, Christoph, Sippl, Wolfgang, Ritter, Christoph, Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009873/
https://www.ncbi.nlm.nih.gov/pubmed/29098884
http://dx.doi.org/10.1080/14756366.2017.1370583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009873/
https://www.ncbi.nlm.nih.gov/pubmed/29098884
http://dx.doi.org/10.1080/14756366.2017.1370583

Ejemplares similares